Who Paid My Doc
Kevin Lunde
Facial Plastic Surgery Plano, TX Medical Doctor
NPI 1710945886 CMS profile 169023
4708 Alliance Blvd, Suite 780, Plano, TX 75093
General payments
$1,595
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$73,759
Through program year 2025, Kevin Lunde of Plano, TX is reported in the CMS Open Payments database as having received $1,595 across 43 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $73,759 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 56th percentile of Facial Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $771 | 12 | |
| 2024 | General | $66 | 2 | |
| 2023 | General | $179 | 9 | |
| 2022 | General | $43 | 2 | |
| 2021 | General | $104 | 4 | |
| 2020 | General | $162 | 7 | |
| 2019 | General | $272 | 7 |
Beside peers
- Kevin Lunde
- Facial Plastic Surgery median
- Middle half of Facial Plastic Surgery
- National median
In program year 2025, general payments to Kevin Lunde were reported at $771. Among 437 Facial Plastic Surgery profiles paid that year, the median was $270 and the middle half received between $116 and $579.
Show as a table
| Year | Kevin Lunde | Facial Plastic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $272 | $225 | $92–$651 | $163 |
| 2020 | $162 | $132 | $45–$323 | $114 |
| 2021 | $104 | $186 | $67–$558 | $132 |
| 2022 | $43 | $218 | $83–$594 | $149 |
| 2023 | $179 | $237 | $94–$564 | $160 |
| 2024 | $66 | $233 | $104–$575 | $164 |
| 2025 | $771 | $270 | $116–$579 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
227
Drug cost
$3,478
Branded share of claims
24.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ipratropium Bromide | Generic | 106 | $2,487 | |
| Ofloxacin | Generic | 27 | $478 | |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | Brand | 42 | $234 | |
| Mupirocin | Generic | 20 | $142 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 14 | $110 | |
| Prednisone | Generic | 18 | $27 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 64 billing codesPaid by Medicare
$95,387
Medicare patients
694
Services billed
2,044
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 53% | |
| Ischemic heart disease | 34% | |
| Diabetes | 27% | |
| Chronic kidney disease | 25% | |
| Depression | 21% | |
| Osteoporosis | 20% | |
| Atrial fibrillation | 19% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
43 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Facial Plastic Surgery in Texas
Jose Barrera
Facial Plastic Surgery · San Antonio, TX
Eli Gordin
Facial Plastic Surgery · Dallas, TX
Ifeolumipo Sofola
Facial Plastic Surgery · The Woodlands, TX
Vu Ho
Facial Plastic Surgery · Plano, TX
Edward Buckingham
Facial Plastic Surgery · Austin, TX
Tang Ho
Facial Plastic Surgery · Houston, TX
Related records
Facial Plastic Surgery in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Facial Plastic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.